

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.48291361 |
| 2 | response to pheromone (GO:0019236) | 4.04174871 |
| 3 | cellular potassium ion homeostasis (GO:0030007) | 3.89847423 |
| 4 | cerebellar granule cell differentiation (GO:0021707) | 3.64168657 |
| 5 | sodium ion export (GO:0071436) | 3.47408596 |
| 6 | neuronal ion channel clustering (GO:0045161) | 3.31786498 |
| 7 | cell communication by electrical coupling (GO:0010644) | 3.30835360 |
| 8 | potassium ion homeostasis (GO:0055075) | 3.30204150 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.29990352 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24495931 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.20363717 |
| 12 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.13311184 |
| 13 | positive regulation of synapse maturation (GO:0090129) | 3.00550955 |
| 14 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98135707 |
| 15 | amino acid import (GO:0043090) | 2.95553539 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.92623523 |
| 17 | regulation of ARF protein signal transduction (GO:0032012) | 2.91357597 |
| 18 | synaptic vesicle maturation (GO:0016188) | 2.88855558 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 2.88200463 |
| 20 | alanine transport (GO:0032328) | 2.86917623 |
| 21 | neuromuscular process controlling balance (GO:0050885) | 2.86613629 |
| 22 | potassium ion import (GO:0010107) | 2.85658962 |
| 23 | retinal rod cell development (GO:0046548) | 2.84218479 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.79064404 |
| 25 | regulation of female receptivity (GO:0045924) | 2.78501730 |
| 26 | cerebellar Purkinje cell layer development (GO:0021680) | 2.75773571 |
| 27 | creatine metabolic process (GO:0006600) | 2.73466164 |
| 28 | cellular sodium ion homeostasis (GO:0006883) | 2.71021554 |
| 29 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.67097420 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 2.66677231 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.66677231 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.59589034 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 2.58748275 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.57498271 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 2.52513583 |
| 36 | nitric oxide mediated signal transduction (GO:0007263) | 2.50495297 |
| 37 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.49693426 |
| 38 | detection of light stimulus involved in visual perception (GO:0050908) | 2.49277072 |
| 39 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.49277072 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 2.48894659 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.48894659 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 2.48609339 |
| 43 | detection of calcium ion (GO:0005513) | 2.46932138 |
| 44 | macroautophagy (GO:0016236) | 2.46839974 |
| 45 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.44153413 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44000284 |
| 47 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.43777541 |
| 48 | mating behavior (GO:0007617) | 2.43007056 |
| 49 | protein retention in ER lumen (GO:0006621) | 2.41938430 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 2.41821580 |
| 51 | COPI coating of Golgi vesicle (GO:0048205) | 2.41821580 |
| 52 | virion attachment to host cell (GO:0019062) | 2.41134045 |
| 53 | adhesion of symbiont to host cell (GO:0044650) | 2.41134045 |
| 54 | exploration behavior (GO:0035640) | 2.41057774 |
| 55 | barbed-end actin filament capping (GO:0051016) | 2.40279553 |
| 56 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.39610253 |
| 57 | vocalization behavior (GO:0071625) | 2.39510895 |
| 58 | layer formation in cerebral cortex (GO:0021819) | 2.39423890 |
| 59 | postsynaptic membrane organization (GO:0001941) | 2.39036354 |
| 60 | regulation of synapse maturation (GO:0090128) | 2.39011112 |
| 61 | cell volume homeostasis (GO:0006884) | 2.38950823 |
| 62 | female mating behavior (GO:0060180) | 2.38849697 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 2.38737801 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 2.38695119 |
| 65 | cardiac muscle contraction (GO:0060048) | 2.38477094 |
| 66 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.36939025 |
| 67 | cGMP-mediated signaling (GO:0019934) | 2.36507636 |
| 68 | L-serine transport (GO:0015825) | 2.35931872 |
| 69 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.35178153 |
| 70 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.34392467 |
| 71 | regulation of synaptic vesicle transport (GO:1902803) | 2.33634952 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.33282185 |
| 73 | astrocyte development (GO:0014002) | 2.32989263 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.31269267 |
| 75 | ovulation cycle (GO:0042698) | 2.30711575 |
| 76 | glutamate secretion (GO:0014047) | 2.29478503 |
| 77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.29393865 |
| 78 | locomotory exploration behavior (GO:0035641) | 2.28967397 |
| 79 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.28915033 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.28756750 |
| 81 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.28155376 |
| 82 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.27451601 |
| 83 | response to leptin (GO:0044321) | 2.27322845 |
| 84 | regulation of neurotransmitter levels (GO:0001505) | 2.27319262 |
| 85 | glucocorticoid biosynthetic process (GO:0006704) | 2.27046638 |
| 86 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.26393140 |
| 87 | NADH metabolic process (GO:0006734) | 2.26389130 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 2.26261630 |
| 89 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.25803930 |
| 90 | peripheral nervous system axon ensheathment (GO:0032292) | 2.25416660 |
| 91 | myelination in peripheral nervous system (GO:0022011) | 2.25416660 |
| 92 | astrocyte differentiation (GO:0048708) | 2.25401456 |
| 93 | synaptic vesicle endocytosis (GO:0048488) | 2.25216765 |
| 94 | neuron projection regeneration (GO:0031102) | 2.24601412 |
| 95 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.24557123 |
| 96 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.24292610 |
| 97 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.24159808 |
| 98 | glycine transport (GO:0015816) | 2.24097085 |
| 99 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.23967227 |
| 100 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.23294092 |
| 101 | response to epinephrine (GO:0071871) | 2.22369867 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.21928080 |
| 103 | acidic amino acid transport (GO:0015800) | 2.20371519 |
| 104 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.20313219 |
| 105 | regulation of cell communication by electrical coupling (GO:0010649) | 2.19044494 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 2.18355459 |
| 107 | neurotransmitter secretion (GO:0007269) | 2.18185818 |
| 108 | eye photoreceptor cell differentiation (GO:0001754) | 2.18165371 |
| 109 | photoreceptor cell differentiation (GO:0046530) | 2.18165371 |
| 110 | keratan sulfate catabolic process (GO:0042340) | 2.17381344 |
| 111 | response to dietary excess (GO:0002021) | 2.15947038 |
| 112 | innervation (GO:0060384) | 2.15854431 |
| 113 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.15483783 |
| 114 | glucocorticoid metabolic process (GO:0008211) | 2.15179927 |
| 115 | cellular response to catecholamine stimulus (GO:0071870) | 2.14530775 |
| 116 | ketone body metabolic process (GO:1902224) | 2.14046020 |
| 117 | sodium ion homeostasis (GO:0055078) | 2.13711588 |
| 118 | chondroitin sulfate catabolic process (GO:0030207) | 2.13358171 |
| 119 | estrogen biosynthetic process (GO:0006703) | 2.12305354 |
| 120 | gamma-aminobutyric acid transport (GO:0015812) | 2.11386333 |
| 121 | positive regulation of potassium ion transport (GO:0043268) | 2.11105636 |
| 122 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.09425022 |
| 123 | toxin metabolic process (GO:0009404) | 2.08683817 |
| 124 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.08560844 |
| 125 | neuronal action potential propagation (GO:0019227) | 2.07896989 |
| 126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.03814900 |
| 127 | very long-chain fatty acid metabolic process (GO:0000038) | 2.03737261 |
| 128 | response to methylmercury (GO:0051597) | 2.01456962 |
| 129 | membrane repolarization (GO:0086009) | 2.01388746 |
| 130 | regulation of autophagic vacuole assembly (GO:2000785) | 2.00868652 |
| 131 | adhesion of symbiont to host (GO:0044406) | 2.00659579 |
| 132 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.00473042 |
| 133 | cell communication involved in cardiac conduction (GO:0086065) | 2.00259317 |
| 134 | protein localization to synapse (GO:0035418) | 1.99986380 |
| 135 | regulation of membrane repolarization (GO:0060306) | 1.99132224 |
| 136 | C4-dicarboxylate transport (GO:0015740) | 1.99015114 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 1.97275036 |
| 138 | axon ensheathment in central nervous system (GO:0032291) | 1.96716670 |
| 139 | central nervous system myelination (GO:0022010) | 1.96716670 |
| 140 | iron coordination entity transport (GO:1901678) | 1.96666660 |
| 141 | short-chain fatty acid metabolic process (GO:0046459) | 1.95913325 |
| 142 | cellular modified amino acid catabolic process (GO:0042219) | 1.94839081 |
| 143 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.94520554 |
| 144 | L-amino acid import (GO:0043092) | 1.94371334 |
| 145 | neurotransmitter transport (GO:0006836) | 1.93842177 |
| 146 | regulation of cholesterol homeostasis (GO:2000188) | 1.93754675 |
| 147 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.92806051 |
| 148 | serine transport (GO:0032329) | 1.92493897 |
| 149 | lysine catabolic process (GO:0006554) | 1.91807762 |
| 150 | lysine metabolic process (GO:0006553) | 1.91807762 |
| 151 | neuron remodeling (GO:0016322) | 1.91522698 |
| 152 | reverse cholesterol transport (GO:0043691) | 1.90291012 |
| 153 | fatty acid beta-oxidation (GO:0006635) | 1.90184461 |
| 154 | regulation of vesicle fusion (GO:0031338) | 1.90031033 |
| 155 | activation of protein kinase A activity (GO:0034199) | 1.89808066 |
| 156 | regulation of beta-amyloid formation (GO:1902003) | 1.89729055 |
| 157 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.89560337 |
| 158 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 1.89134132 |
| 159 | tricarboxylic acid metabolic process (GO:0072350) | 1.88992760 |
| 160 | membrane hyperpolarization (GO:0060081) | 1.88623842 |
| 161 | nucleoside diphosphate catabolic process (GO:0009134) | 1.87458916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52668454 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52061821 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.42141230 |
| 4 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25781115 |
| 5 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24491996 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23101841 |
| 7 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20531280 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19386728 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17037184 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16488302 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16488302 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09544610 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04630590 |
| 14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04022768 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03081504 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97346272 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.96691080 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96286969 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84345717 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78089004 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77236680 |
| 22 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74065917 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72950608 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71535896 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69336683 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61295355 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54526093 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53582236 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52382771 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48514987 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48299116 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43244413 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41641738 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.40433455 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36510786 |
| 36 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36510786 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35022005 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33873732 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30925867 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28709784 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28512692 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28036437 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26496212 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26401866 |
| 45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25756680 |
| 46 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25718222 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25535341 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24922448 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24803657 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24008899 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23629958 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23059157 |
| 53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22706242 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22412609 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21896490 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21892430 |
| 57 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20461918 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19168553 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18286656 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17692682 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17315692 |
| 62 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16024705 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15826845 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15449719 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14340109 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13937452 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13210612 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12698062 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11809465 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11388021 |
| 71 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09005529 |
| 72 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08836124 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.08296986 |
| 74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07358810 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06358329 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04740146 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04239002 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04234722 |
| 79 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.04175146 |
| 80 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03180167 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02979940 |
| 82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01357301 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00949934 |
| 84 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00923581 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00849709 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00737990 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00525051 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99492647 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99138219 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98909979 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98642350 |
| 92 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98604335 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98601681 |
| 94 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97959993 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97328068 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95599984 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95498616 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94970321 |
| 99 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94466639 |
| 100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94384217 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94383861 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94238891 |
| 103 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93454461 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91931602 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91774144 |
| 106 | AR_19668381_ChIP-Seq_PC3_Human | 0.91477476 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90852584 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90843358 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90161402 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90143334 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90078538 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89332449 |
| 113 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88378200 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88218005 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88217316 |
| 116 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.87714408 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87155763 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85854445 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85821140 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84796134 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84747159 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84747159 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84562463 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84416693 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84032055 |
| 126 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83867232 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82585236 |
| 128 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.81776056 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77487742 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77365779 |
| 131 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77120280 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.77105587 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.76673851 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76179575 |
| 135 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.75643639 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75319602 |
| 137 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.74960473 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74606598 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74419524 |
| 140 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74330601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 2.84260877 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 2.81787649 |
| 3 | MP0004043_abnormal_pH_regulation | 2.51894515 |
| 4 | MP0002909_abnormal_adrenal_gland | 2.51841548 |
| 5 | MP0000013_abnormal_adipose_tissue | 2.36808673 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.17455046 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.15121912 |
| 8 | MP0004885_abnormal_endolymph | 2.09641554 |
| 9 | MP0003283_abnormal_digestive_organ | 2.07530246 |
| 10 | MP0001502_abnormal_circadian_rhythm | 2.07410942 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.00521009 |
| 12 | MP0002090_abnormal_vision | 2.00478224 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 1.98786767 |
| 14 | MP0003329_amyloid_beta_deposits | 1.98512834 |
| 15 | MP0010386_abnormal_urinary_bladder | 1.97101629 |
| 16 | MP0005670_abnormal_white_adipose | 1.92471879 |
| 17 | MP0003011_delayed_dark_adaptation | 1.90645766 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 1.88651906 |
| 19 | MP0003183_abnormal_peptide_metabolism | 1.88315046 |
| 20 | MP0003195_calcinosis | 1.85465724 |
| 21 | MP0005253_abnormal_eye_physiology | 1.83681101 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.83036061 |
| 23 | MP0003690_abnormal_glial_cell | 1.82349848 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.81672465 |
| 25 | MP0004270_analgesia | 1.76678771 |
| 26 | MP0005275_abnormal_skin_tensile | 1.74692079 |
| 27 | MP0003279_aneurysm | 1.72262762 |
| 28 | MP0001958_emphysema | 1.70862087 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.67164831 |
| 30 | MP0002064_seizures | 1.63602447 |
| 31 | MP0000747_muscle_weakness | 1.62074334 |
| 32 | MP0005365_abnormal_bile_salt | 1.60375275 |
| 33 | MP0002272_abnormal_nervous_system | 1.53928983 |
| 34 | MP0000749_muscle_degeneration | 1.53569537 |
| 35 | MP0001486_abnormal_startle_reflex | 1.50033672 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.49442723 |
| 37 | MP0004510_myositis | 1.47935740 |
| 38 | MP0001984_abnormal_olfaction | 1.45917849 |
| 39 | MP0009840_abnormal_foam_cell | 1.45793265 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.43060421 |
| 41 | MP0002229_neurodegeneration | 1.42054940 |
| 42 | MP0009046_muscle_twitch | 1.42011905 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.40728089 |
| 44 | MP0005360_urolithiasis | 1.40006332 |
| 45 | MP0003646_muscle_fatigue | 1.37358965 |
| 46 | MP0003880_abnormal_central_pattern | 1.35490511 |
| 47 | MP0003633_abnormal_nervous_system | 1.35045208 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.33621363 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.31847827 |
| 50 | MP0004858_abnormal_nervous_system | 1.30573215 |
| 51 | * MP0003634_abnormal_glial_cell | 1.30171327 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.28814602 |
| 53 | MP0005171_absent_coat_pigmentation | 1.28317750 |
| 54 | MP0009745_abnormal_behavioral_response | 1.27596902 |
| 55 | MP0005332_abnormal_amino_acid | 1.25735873 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.25371210 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.24795345 |
| 58 | MP0002822_catalepsy | 1.23958664 |
| 59 | MP0000759_abnormal_skeletal_muscle | 1.23029460 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.22224454 |
| 61 | MP0004130_abnormal_muscle_cell | 1.21993494 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.21913306 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.20987543 |
| 64 | MP0000751_myopathy | 1.20740095 |
| 65 | MP0000604_amyloidosis | 1.20574922 |
| 66 | MP0001905_abnormal_dopamine_level | 1.20090075 |
| 67 | MP0004087_abnormal_muscle_fiber | 1.19568776 |
| 68 | MP0005423_abnormal_somatic_nervous | 1.18118715 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.17195013 |
| 70 | MP0000639_abnormal_adrenal_gland | 1.16242584 |
| 71 | MP0000230_abnormal_systemic_arterial | 1.14551945 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.14527172 |
| 73 | MP0005535_abnormal_body_temperature | 1.11881603 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11625429 |
| 75 | MP0003879_abnormal_hair_cell | 1.11329884 |
| 76 | MP0005195_abnormal_posterior_eye | 1.10814517 |
| 77 | MP0002971_abnormal_brown_adipose | 1.08479045 |
| 78 | MP0006138_congestive_heart_failure | 1.08250609 |
| 79 | MP0003075_altered_response_to | 1.07110954 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.06995788 |
| 81 | * MP0002067_abnormal_sensory_capabilities | 1.06841777 |
| 82 | MP0002269_muscular_atrophy | 1.06528939 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.05961533 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 1.05572731 |
| 85 | MP0003252_abnormal_bile_duct | 1.05570150 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 1.05300536 |
| 87 | MP0010368_abnormal_lymphatic_system | 1.04416185 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 1.03713918 |
| 89 | MP0008874_decreased_physiological_sensi | 1.03713048 |
| 90 | MP0001501_abnormal_sleep_pattern | 1.03606004 |
| 91 | MP0008569_lethality_at_weaning | 1.03011501 |
| 92 | MP0003172_abnormal_lysosome_physiology | 1.02695963 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 1.02689351 |
| 94 | MP0004215_abnormal_myocardial_fiber | 1.02461627 |
| 95 | MP0009384_cardiac_valve_regurgitation | 1.02044712 |
| 96 | MP0001765_abnormal_ion_homeostasis | 1.01627999 |
| 97 | MP0005165_increased_susceptibility_to | 1.01349813 |
| 98 | MP0005330_cardiomyopathy | 1.00714238 |
| 99 | MP0000920_abnormal_myelination | 0.99531567 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.98569690 |
| 101 | MP0004036_abnormal_muscle_relaxation | 0.98021016 |
| 102 | MP0002557_abnormal_social/conspecific_i | 0.97489534 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.96613872 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.96062398 |
| 105 | MP0002735_abnormal_chemical_nociception | 0.94995019 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.94179776 |
| 107 | MP0004233_abnormal_muscle_weight | 0.94162789 |
| 108 | MP0004142_abnormal_muscle_tone | 0.94074890 |
| 109 | * MP0002066_abnormal_motor_capabilities/c | 0.93642734 |
| 110 | * MP0002882_abnormal_neuron_morphology | 0.93522965 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.93153812 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.93119094 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.91605353 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.91578543 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.91164661 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.90636724 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.90410819 |
| 118 | MP0003631_nervous_system_phenotype | 0.89907226 |
| 119 | MP0005409_darkened_coat_color | 0.89822480 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.89377797 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.88749089 |
| 122 | MP0004085_abnormal_heartbeat | 0.87041017 |
| 123 | MP0001970_abnormal_pain_threshold | 0.86799679 |
| 124 | MP0005386_behavior/neurological_phenoty | 0.85614350 |
| 125 | MP0004924_abnormal_behavior | 0.85614350 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.84863283 |
| 127 | MP0001756_abnormal_urination | 0.84710735 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.82636858 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82568731 |
| 130 | MP0005369_muscle_phenotype | 0.82305416 |
| 131 | MP0002106_abnormal_muscle_physiology | 0.81695431 |
| 132 | MP0003632_abnormal_nervous_system | 0.81630053 |
| 133 | MP0003953_abnormal_hormone_level | 0.81542888 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.81486201 |
| 135 | MP0004272_abnormal_basement_membrane | 0.81321991 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.81247289 |
| 137 | MP0005508_abnormal_skeleton_morphology | 0.80110120 |
| 138 | MP0001299_abnormal_eye_distance/ | 0.79949149 |
| 139 | MP0002972_abnormal_cardiac_muscle | 0.79859722 |
| 140 | MP0004811_abnormal_neuron_physiology | 0.79049617 |
| 141 | MP0001177_atelectasis | 0.79035332 |
| 142 | MP0008260_abnormal_autophagy | 0.77108208 |
| 143 | MP0001542_abnormal_bone_strength | 0.75997567 |
| 144 | MP0005166_decreased_susceptibility_to | 0.75759822 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.73218924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ketoacidosis (HP:0001993) | 3.80343106 |
| 2 | Asymmetric septal hypertrophy (HP:0001670) | 3.65338287 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.58587204 |
| 4 | Congenital stationary night blindness (HP:0007642) | 3.56879296 |
| 5 | Central scotoma (HP:0000603) | 3.42415685 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.33444195 |
| 7 | Retinal atrophy (HP:0001105) | 3.24319314 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 3.22143935 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.17824520 |
| 10 | Bundle branch block (HP:0011710) | 3.09197841 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.08297999 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.07636159 |
| 13 | Ketosis (HP:0001946) | 3.01752311 |
| 14 | Obstructive sleep apnea (HP:0002870) | 2.98992684 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 2.87442218 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.82208408 |
| 17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.81750711 |
| 18 | Increased variability in muscle fiber diameter (HP:0003557) | 2.80236727 |
| 19 | Dysostosis multiplex (HP:0000943) | 2.78377894 |
| 20 | Muscle fiber splitting (HP:0003555) | 2.77948568 |
| 21 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.75510042 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.75176139 |
| 23 | Abnormality of binocular vision (HP:0011514) | 2.73773364 |
| 24 | Diplopia (HP:0000651) | 2.73773364 |
| 25 | Atrioventricular block (HP:0001678) | 2.72164359 |
| 26 | Increased circulating renin level (HP:0000848) | 2.70838212 |
| 27 | Scotoma (HP:0000575) | 2.67696489 |
| 28 | Visual hallucinations (HP:0002367) | 2.63798036 |
| 29 | Abnormal atrioventricular conduction (HP:0005150) | 2.62306546 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 2.59505374 |
| 31 | Abnormality of complement system (HP:0005339) | 2.56549925 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.55347501 |
| 33 | Symptomatic seizures (HP:0011145) | 2.54420989 |
| 34 | Focal seizures (HP:0007359) | 2.52982962 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.52574730 |
| 36 | Complement deficiency (HP:0004431) | 2.52137729 |
| 37 | Heart block (HP:0012722) | 2.50679100 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 2.50309262 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50272497 |
| 40 | Decreased circulating renin level (HP:0003351) | 2.49855119 |
| 41 | Foot dorsiflexor weakness (HP:0009027) | 2.49124356 |
| 42 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.48906083 |
| 43 | Depression (HP:0000716) | 2.42317545 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41077623 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.37972187 |
| 46 | Increased connective tissue (HP:0009025) | 2.37909862 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37737221 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.37737221 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33740901 |
| 50 | Pheochromocytoma (HP:0002666) | 2.33154483 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32191925 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31885478 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31885478 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31885478 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.31603045 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.31380289 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.31380289 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.31380289 |
| 59 | Hyperaldosteronism (HP:0000859) | 2.30992975 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.30931177 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.27874547 |
| 62 | Abnormality of the foot musculature (HP:0001436) | 2.27707356 |
| 63 | Shallow orbits (HP:0000586) | 2.26946158 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.26219315 |
| 65 | Spinal rigidity (HP:0003306) | 2.25613496 |
| 66 | Abnormality of renin-angiotensin system (HP:0000847) | 2.25456371 |
| 67 | Hypokalemic alkalosis (HP:0001949) | 2.25040366 |
| 68 | Gout (HP:0001997) | 2.22260042 |
| 69 | Axonal loss (HP:0003447) | 2.20996283 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20905595 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20905595 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20905595 |
| 73 | Hemiparesis (HP:0001269) | 2.19791871 |
| 74 | Sudden death (HP:0001699) | 2.19611152 |
| 75 | Epileptic encephalopathy (HP:0200134) | 2.18941756 |
| 76 | Keratoconus (HP:0000563) | 2.18531098 |
| 77 | Increased corneal curvature (HP:0100692) | 2.18531098 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16930222 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.16814821 |
| 80 | Myoglobinuria (HP:0002913) | 2.16632505 |
| 81 | Focal motor seizures (HP:0011153) | 2.15497496 |
| 82 | Xanthomatosis (HP:0000991) | 2.15451753 |
| 83 | Late onset (HP:0003584) | 2.13990265 |
| 84 | Muscle fiber inclusion bodies (HP:0100299) | 2.13600153 |
| 85 | Truncal ataxia (HP:0002078) | 2.13529053 |
| 86 | Turricephaly (HP:0000262) | 2.11651941 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.11637045 |
| 88 | Postural instability (HP:0002172) | 2.11375288 |
| 89 | EMG: myopathic abnormalities (HP:0003458) | 2.11290498 |
| 90 | Nemaline bodies (HP:0003798) | 2.10526072 |
| 91 | Annular pancreas (HP:0001734) | 2.10458665 |
| 92 | Aortic aneurysm (HP:0004942) | 2.09939907 |
| 93 | Large for gestational age (HP:0001520) | 2.08933950 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 2.08413660 |
| 95 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.08369262 |
| 96 | Peripheral hypomyelination (HP:0007182) | 2.07266981 |
| 97 | Febrile seizures (HP:0002373) | 2.07162173 |
| 98 | Mutism (HP:0002300) | 2.06954164 |
| 99 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.06831901 |
| 100 | Scanning speech (HP:0002168) | 2.04728668 |
| 101 | Broad metatarsal (HP:0001783) | 2.04599982 |
| 102 | Hypokalemia (HP:0002900) | 2.04557011 |
| 103 | Nuclear cataract (HP:0100018) | 2.03947968 |
| 104 | Rigidity (HP:0002063) | 2.03503432 |
| 105 | Papilledema (HP:0001085) | 2.02944405 |
| 106 | Action tremor (HP:0002345) | 2.02736293 |
| 107 | Distal upper limb amyotrophy (HP:0007149) | 2.02636523 |
| 108 | Upper limb amyotrophy (HP:0009129) | 2.02636523 |
| 109 | Arterial tortuosity (HP:0005116) | 2.01698812 |
| 110 | Dysmetria (HP:0001310) | 1.99695761 |
| 111 | Exercise-induced myalgia (HP:0003738) | 1.99609445 |
| 112 | Focal dystonia (HP:0004373) | 1.99036885 |
| 113 | Anxiety (HP:0000739) | 1.98652245 |
| 114 | Ankle clonus (HP:0011448) | 1.98270186 |
| 115 | Glomerulonephritis (HP:0000099) | 1.97928513 |
| 116 | Atonic seizures (HP:0010819) | 1.96577936 |
| 117 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96427505 |
| 118 | Agitation (HP:0000713) | 1.95286010 |
| 119 | Myokymia (HP:0002411) | 1.94976696 |
| 120 | Wormian bones (HP:0002645) | 1.94376745 |
| 121 | Torticollis (HP:0000473) | 1.93967737 |
| 122 | Rapidly progressive (HP:0003678) | 1.93523293 |
| 123 | Hypoplasia of the iris (HP:0007676) | 1.93483251 |
| 124 | Tetraplegia (HP:0002445) | 1.92504603 |
| 125 | Intention tremor (HP:0002080) | 1.92426943 |
| 126 | Neuroendocrine neoplasm (HP:0100634) | 1.92138487 |
| 127 | Pigmentary retinal degeneration (HP:0001146) | 1.91318904 |
| 128 | Renal salt wasting (HP:0000127) | 1.89586416 |
| 129 | Exercise-induced muscle cramps (HP:0003710) | 1.89285473 |
| 130 | Hyperglycinuria (HP:0003108) | 1.88767510 |
| 131 | Megalencephaly (HP:0001355) | 1.88493091 |
| 132 | Epileptiform EEG discharges (HP:0011182) | 1.87679714 |
| 133 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87301713 |
| 134 | Round ear (HP:0100830) | 1.87269999 |
| 135 | Hammertoe (HP:0001765) | 1.87230425 |
| 136 | Lower limb amyotrophy (HP:0007210) | 1.86985760 |
| 137 | Insomnia (HP:0100785) | 1.85839104 |
| 138 | Apathy (HP:0000741) | 1.85137041 |
| 139 | Metabolic alkalosis (HP:0200114) | 1.84706988 |
| 140 | Lower limb muscle weakness (HP:0007340) | 1.84567127 |
| 141 | Cervical subluxation (HP:0003308) | 1.84119898 |
| 142 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83770318 |
| 143 | Spastic gait (HP:0002064) | 1.82756420 |
| 144 | Myopathic facies (HP:0002058) | 1.82329855 |
| 145 | Retinal dysplasia (HP:0007973) | 1.81663780 |
| 146 | Adrenal overactivity (HP:0002717) | 1.81622119 |
| 147 | Neck muscle weakness (HP:0000467) | 1.81561073 |
| 148 | Type II lissencephaly (HP:0007260) | 1.81221911 |
| 149 | Humeroradial synostosis (HP:0003041) | 1.80786580 |
| 150 | Synostosis involving the elbow (HP:0003938) | 1.80786580 |
| 151 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80344814 |
| 152 | Muscle stiffness (HP:0003552) | 1.79562228 |
| 153 | Decreased central vision (HP:0007663) | 1.79510997 |
| 154 | Diminished motivation (HP:0000745) | 1.79498477 |
| 155 | Vascular tortuosity (HP:0004948) | 1.79468853 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.78838959 |
| 157 | Difficulty running (HP:0009046) | 1.77759180 |
| 158 | Hypsarrhythmia (HP:0002521) | 1.77016885 |
| 159 | Dysdiadochokinesis (HP:0002075) | 1.76012918 |
| 160 | Abnormal urine output (HP:0012590) | 1.75846238 |
| 161 | Hypoalphalipoproteinemia (HP:0003233) | 1.75081093 |
| 162 | Generalized tonic-clonic seizures (HP:0002069) | 1.74577297 |
| 163 | Amyloidosis (HP:0011034) | 1.74382753 |
| 164 | Progressive visual loss (HP:0000529) | 1.74180554 |
| 165 | Abnormality of potassium homeostasis (HP:0011042) | 1.73821692 |
| 166 | Protuberant abdomen (HP:0001538) | 1.71943149 |
| 167 | Skin nodule (HP:0200036) | 1.71544364 |
| 168 | Prolonged QT interval (HP:0001657) | 1.71518964 |
| 169 | Craniofacial dystonia (HP:0012179) | 1.71056510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 3.39565878 |
| 2 | INSRR | 3.22966645 |
| 3 | WNK3 | 2.51959744 |
| 4 | PHKG2 | 2.23249733 |
| 5 | PHKG1 | 2.23249733 |
| 6 | PRKD3 | 2.11414762 |
| 7 | TESK1 | 2.07574279 |
| 8 | ERN1 | 2.06172252 |
| 9 | BCKDK | 2.04578666 |
| 10 | PINK1 | 1.98400829 |
| 11 | NTRK3 | 1.96778625 |
| 12 | NTRK1 | 1.93711661 |
| 13 | WNK4 | 1.93442481 |
| 14 | TNIK | 1.81222305 |
| 15 | MAP3K9 | 1.71548976 |
| 16 | TRIB3 | 1.66974900 |
| 17 | EPHA4 | 1.65762371 |
| 18 | CAMKK2 | 1.62959972 |
| 19 | TGFBR2 | 1.62131359 |
| 20 | TTN | 1.54650729 |
| 21 | LMTK2 | 1.53924802 |
| 22 | RIPK1 | 1.52673815 |
| 23 | LATS2 | 1.52658208 |
| 24 | PAK6 | 1.52563836 |
| 25 | SIK1 | 1.52216016 |
| 26 | OXSR1 | 1.51694163 |
| 27 | SGK223 | 1.37047358 |
| 28 | SGK494 | 1.37047358 |
| 29 | PAK2 | 1.36447029 |
| 30 | KSR2 | 1.35356704 |
| 31 | MINK1 | 1.27227802 |
| 32 | LIMK1 | 1.27115868 |
| 33 | OBSCN | 1.27094138 |
| 34 | MUSK | 1.25112763 |
| 35 | MARK1 | 1.23224698 |
| 36 | CAMK1G | 1.22916426 |
| 37 | PAK3 | 1.21470920 |
| 38 | STK39 | 1.21267822 |
| 39 | CAMKK1 | 1.19415824 |
| 40 | MOS | 1.19131659 |
| 41 | EEF2K | 1.17529301 |
| 42 | MAP3K11 | 1.15842182 |
| 43 | NTRK2 | 1.12704275 |
| 44 | MAP3K2 | 1.08293708 |
| 45 | MAP2K4 | 1.08269857 |
| 46 | PRKCH | 1.07844836 |
| 47 | HIPK2 | 1.06419008 |
| 48 | DAPK2 | 1.06287266 |
| 49 | DAPK3 | 1.04238027 |
| 50 | WNK1 | 1.02412656 |
| 51 | EPHA3 | 1.01819455 |
| 52 | FGFR2 | 1.00350040 |
| 53 | CDK5 | 0.98865860 |
| 54 | CAMK1D | 0.97114628 |
| 55 | STK38 | 0.96644400 |
| 56 | FER | 0.95955974 |
| 57 | MAPK12 | 0.95579122 |
| 58 | MAP3K4 | 0.94706677 |
| 59 | DYRK1A | 0.92056582 |
| 60 | MAP3K1 | 0.91105685 |
| 61 | TNK2 | 0.91025703 |
| 62 | EPHB1 | 0.90870497 |
| 63 | MAP3K13 | 0.89351069 |
| 64 | TAOK2 | 0.89274449 |
| 65 | PRKD2 | 0.86040654 |
| 66 | DMPK | 0.84970657 |
| 67 | CAMK2D | 0.84546417 |
| 68 | MAPKAPK3 | 0.84496246 |
| 69 | DDR2 | 0.82073101 |
| 70 | PDGFRA | 0.81983133 |
| 71 | IRAK2 | 0.81319415 |
| 72 | GRK5 | 0.80474801 |
| 73 | PIM2 | 0.78940933 |
| 74 | PRKCG | 0.78864800 |
| 75 | ABL2 | 0.78585340 |
| 76 | RET | 0.78263024 |
| 77 | PRKCE | 0.77508356 |
| 78 | UHMK1 | 0.77443575 |
| 79 | NEK6 | 0.75672492 |
| 80 | DAPK1 | 0.73594273 |
| 81 | MAP2K7 | 0.73458052 |
| 82 | PTK6 | 0.73251783 |
| 83 | SCYL2 | 0.72985488 |
| 84 | ROCK2 | 0.72671143 |
| 85 | BRAF | 0.71239672 |
| 86 | MAPK7 | 0.69309994 |
| 87 | DYRK1B | 0.68845678 |
| 88 | ARAF | 0.68425703 |
| 89 | CAMK1 | 0.68414448 |
| 90 | PKN1 | 0.67462771 |
| 91 | ROCK1 | 0.66699515 |
| 92 | CDK15 | 0.66292537 |
| 93 | CAMK2A | 0.66232684 |
| 94 | MAP3K6 | 0.65470923 |
| 95 | PIK3CG | 0.65241015 |
| 96 | PTK2 | 0.64678394 |
| 97 | RPS6KA2 | 0.64435571 |
| 98 | PRPF4B | 0.63773137 |
| 99 | PDPK1 | 0.62975330 |
| 100 | CAMK2G | 0.62649364 |
| 101 | CDK11A | 0.61541654 |
| 102 | TESK2 | 0.61057492 |
| 103 | MAPK4 | 0.59754078 |
| 104 | GRK7 | 0.58731692 |
| 105 | MAPK10 | 0.58711195 |
| 106 | PRKAA1 | 0.58160144 |
| 107 | MAP2K3 | 0.57788972 |
| 108 | CDK18 | 0.57768999 |
| 109 | CDC42BPA | 0.57764711 |
| 110 | MET | 0.57136481 |
| 111 | SGK2 | 0.57087246 |
| 112 | SGK3 | 0.55407036 |
| 113 | PRKD1 | 0.54470141 |
| 114 | BMX | 0.54465439 |
| 115 | CDK14 | 0.54379417 |
| 116 | CDK19 | 0.53332979 |
| 117 | MARK2 | 0.53196629 |
| 118 | AKT2 | 0.51993774 |
| 119 | PRKAA2 | 0.51853504 |
| 120 | PRKCZ | 0.51184000 |
| 121 | MAP3K3 | 0.50068203 |
| 122 | TBK1 | 0.49343651 |
| 123 | CAMK2B | 0.49042866 |
| 124 | MAP2K1 | 0.48727706 |
| 125 | PRKACG | 0.47817948 |
| 126 | ICK | 0.47572921 |
| 127 | MAPK13 | 0.46595848 |
| 128 | MAP3K7 | 0.46496877 |
| 129 | MYLK | 0.46489944 |
| 130 | TIE1 | 0.46001884 |
| 131 | FGFR4 | 0.45690461 |
| 132 | GRK1 | 0.45439100 |
| 133 | MAP2K6 | 0.45367338 |
| 134 | PRKACA | 0.44598667 |
| 135 | PRKG2 | 0.43381233 |
| 136 | PASK | 0.42656515 |
| 137 | MAPKAPK5 | 0.42483639 |
| 138 | TYRO3 | 0.42188311 |
| 139 | PDK1 | 0.42123511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77780936 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.42133191 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95794352 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.89239478 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 1.79011944 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.78871618 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77900372 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77560951 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76718772 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76239694 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74505236 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69151529 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57863586 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.54847400 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.53936036 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38872257 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37951708 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34497870 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32216018 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30042391 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27871904 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27662971 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.26491700 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24827652 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.23802681 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21667779 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19101006 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17979399 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.17405748 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15450671 |
| 31 | * Lysosome_Homo sapiens_hsa04142 | 1.12400479 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10772410 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10601843 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.09152138 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08281976 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07665139 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07173688 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.06032124 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05215442 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.04654676 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03227702 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02038338 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02026669 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.01540219 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.01499635 |
| 46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00692634 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98785674 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98688908 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98481593 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96829813 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96723089 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94600525 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94058371 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93456383 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92914863 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90348325 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.89929446 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88650479 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88442719 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.88421288 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88235986 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.83712399 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.83700129 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83465205 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82699723 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82673408 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82503001 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82348539 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82168825 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82030564 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81920514 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81781557 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79723761 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78597397 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.77432506 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77378285 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76247362 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75448312 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74053538 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73640754 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.72588822 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69971795 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.69901452 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69500766 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69159953 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68325476 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67320399 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.65679648 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64807243 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63698701 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63213993 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61725119 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61672097 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61138246 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60737944 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60519636 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59089614 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58623946 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58574779 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58438116 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58102582 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57209784 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57169231 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56779236 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56701946 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56674941 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56511022 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54123550 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53572443 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53403324 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53136538 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.53116254 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53098607 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53074110 |
| 115 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51530578 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51236558 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50335108 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49859621 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49491655 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48514967 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48024959 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47715596 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47544497 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47223934 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.47013116 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46999800 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.46985612 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46873427 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46594858 |
| 130 | Protein export_Homo sapiens_hsa03060 | 0.45209728 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42652840 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41730084 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41707923 |

